# CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCC

> **NCT06609070** · NA · NOT_YET_RECRUITING · sponsor: **Guangzhou University of Traditional Chinese Medicine** · enrollment: 30 (estimated)

## Conditions studied

- Squamous Cell Carcinoma
- Squamous Cell Carcinoma of the Oral Cavity

## Interventions

- **DRUG:** CHG0521 Oral Coating

## Key facts

- **NCT ID:** NCT06609070
- **Lead sponsor:** Guangzhou University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-15
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06609070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06609070, "CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06609070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*